City State Bank’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$406K Buy
3,212
+28
+0.9% +$3.69K 0.09% 150
2026
Q1
$444K Buy
3,184
+157
+5% +$22K 0.12% 136
2025
Q4
$372K Sell
3,027
-112
-4% -$13.6K 0.1% 149
2025
Q3
$348K Sell
3,139
-78
-2% -$8.87K 0.1% 154
2025
Q2
$357K Hold
3,217
0.11% 152
2025
Q1
$360K Sell
3,217
-170
-5% -$17.5K 0.12% 138
2024
Q4
$313K Sell
3,387
-288
-8% -$25.9K 0.11% 153
2024
Q3
$308K Sell
3,675
-236
-6% -$18K 0.11% 149
2024
Q2
$268K Sell
3,911
-48
-1% -$3.2K 0.11% 151
2024
Q1
$290K Sell
3,959
-24
-0.6% -$1.85K 0.13% 143
2023
Q4
$323K Sell
3,983
-176
-4% -$13.7K 0.16% 124
2023
Q3
$312K Sell
4,159
-24
-0.6% -$1.85K 0.17% 121
2023
Q2
$322K Sell
4,183
-150
-3% -$12K 0.17% 119
2023
Q1
$360K Sell
4,333
-149
-3% -$12.3K 0.21% 109
2022
Q4
$385K Sell
4,482
-128
-3% -$10.1K 0.24% 102
2022
Q3
$284K Buy
4,610
+195
+4% +$12.3K 0.2% 112
2022
Q2
$273K Buy
4,415
+85
+2% +$5.26K 0.19% 120
2022
Q1
$257K Buy
4,330
+455
+12% +$29.1K 0.16% 136
2021
Q4
$281K Buy
+3,875
New +$267K 0.17% 130

Other funds holding GILD

City State Bank's GILD Position: Q2 2026 in Review

City State Bank increased its Gilead Sciences (GILD) stake by 0.88% in Q2 2026, buying an estimated $3.69K and bringing the position to 3,212 shares worth $406K. The position accounts for 0.09% of the portfolio, ranked #150.

City State Bank first reported a position in GILD in Q4 2021 and has held it in 19 quarters since. The position peaked at $444K in Q1 2026. 1,032 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • City State Bank held 3,212 shares of Gilead Sciences worth $406K as of Q2 2026.
  • City State Bank bought 28 Gilead Sciences shares in Q2 2026, an estimated $3.69K.
  • Gilead Sciences made up 0.09% of City State Bank's portfolio in Q2 2026, its #150 holding.
  • City State Bank first reported a position in Gilead Sciences in Q4 2021 and has held it in 19 quarters since.
  • City State Bank's Gilead Sciences position peaked at $444K in Q1 2026.
  • 1,032 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on City State Bank's 13F filing for Q2 2026, filed 14 Jul 2026.